115615-21-9

Basic information

• Product Name: Benzenemethanol, 2-bromo-4,6-dichloro-
• CAS NO: 115615-21-9
• Molecular Formula: C7H5BrCl2O
• Molecular Weight: 255.926
• Mol File: 115615-21-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzenemethanol, 2-bromo-4,6-dichloro-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanol, 2-bromo-4,6-dichloro-(115615-21-9)
• EPA Substance Registry System: Benzenemethanol, 2-bromo-4,6-dichloro-(115615-21-9)

Safety Data

• Hazardous Substances Data: 115615-21-9(Hazardous Substances Data)

Usage

General Description

Benzenemethanol, 2-bromo-4,6-dichloro- is a chemical compound that belongs to the family of organic compounds known as phenols. It is a white to yellow crystalline solid with a molecular formula of C7H6BrCl2O. This chemical is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It has also been identified as a potential environmental pollutant and has been found to be harmful to aquatic organisms. Additionally, it is important to handle this compound with caution as it may have adverse effects on human health if not properly handled.

Upstream product

• 115615-22-0 Acetic acid 2-bromo-4,6-dichloro-benzyl ester 
• 1595-01-3 1-hexyl-4-methyl-benzene 
• 115615-20-8 1-bromo-2-(bromomethyl)-3,5-dichlorobenzene 
• 650598-43-9 2-bromo-4,6-dichlorobenzoic acid 
• 115615-19-5 1-bromo-3,5-dichloro-2-toluene 
• 95-73-8 2,4-dichlorotoluene 

Downstream Products

• 115615-28-6 1-(3,5-DICHLORO-2-HYDROXYMETHYLPHENYL)-1-(2,4-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHANOL 
• 115653-42-4 1-(2,4-dichlorophenyl)-1-(1H-imidazol-1-ylmethyl)-1,3-dihydro-4,6-dichloroisobenzofuran 
• 115615-20-8 1-bromo-2-(bromomethyl)-3,5-dichlorobenzene 
• 115615-27-5 <2-<1-(2,4-dichlorophenyl)oxiranyl>-4,6-dichlorophenyl>methanol 

Relevant articles and documents

Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use

This invention relates to arylaminoaryl-alkyl-substituted imidazolidone-2,4-diones of formula (I) and also to their physiologically tolerated salts: Wherein R, R′, R1 to R10, A, D, E, G, L and p are as defined herein. The invention also relates to processes for preparing them, pharmaceutical compositions comprising them and their therapeutic use. The compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

1-aryl-1-(1H-azol-1-ylalkyl)-1,3-dihydroisobenzofurans, related derivatives and pharmaceutical compositions thereof useful as antifungals

Novel compounds including 1-aryl-1-(1H-imidazol-1-ylmethyl)-1,3-dihydroisobenzofurans such as 1-(4-chlorophenyl)-1-(1H-imidazol-1-ylmethyl)-1,3-dihydroisobenzofuran, and 1-aryl-1-(1H-1,2,4-trizazol-1-ylmethyl)-1,3-dihydroisobenzofurans are disclosed. The